Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Stephens & Co. Downgrades Akoya Biosciences to Equal-Weight, Lowers Price Target to $1.8

Author: Benzinga Newsdesk | March 25, 2025 10:32am
Stephens & Co. analyst Mason Carrico downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Equal-Weight and lowers the price target from $3.5 to $1.8.

Posted In: AKYA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist